5733694: Bard HemoSplit 14.5F LT Dialysis Catheter: Standard, Straight, Tapered Cuff 19cm

Sign in to add this product to your favorites!
| Price: | $11.50 EACH |
|---|---|
| Quantity: | |
| In Stock: | 6 eaches |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 13 hours 31 minutes and choose overnight shipping at checkout for Monday delivery. If you require Saturday delivery, please call to determine if it is available in your area - 888-416-2409. |
Additional Details
BD Bard HemoSplit LT Dialysis Catheter
- Catheter Size: 14.5F
- Polyurethane catheter material affords strength for longevity and softness for flexibility and patient comfort
- 360° Multi-Plane Sideholes reduce the risk of catheter occlusion by the vessel wall which maybe associated with reducing the risk of arterial insufficiency
- Exceptional kink resistance simplifies insertion by allowing greater flexibility in tunnel location
- Guidewire passage/hole on the tip segment facilitates threading for easy over-the-wire insertion
AccessGUDID Info
- FDA Product Code: MSD
- FDA Product Code Name: Catheter, hemodialysis, implanted
- GMDN Term Code: 37278
- GMDN Term Name: Double-lumen haemodialysis catheter, implantable
- GMDN Term Description: An implantable, flexible, double-lumen tube intended to be used for chronic or long-term (> 30 days) vascular access, primarily during haemodialysis, to conduct blood from a patient and returning it after extracorporeal circulation; it may also be used during haemoperfusion and/or apheresis. It is intended for coaxial flow of blood, may be radiopaque, coated with heparin to prevent thrombus formation, and/or include a silver-coated sleeve to retard bacterial growth; devices dedicated to catheter introduction/function (e.g., introducer needle) may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE